Microcrystalline cellulose market to reach $2.72 billion by 2035

The global microcrystalline cellulose market is projected to grow from $1.54 billion in 2026 to $2.72 billion by 2035, driven by pharmaceutical demand, clean-label food reformulation and plant-based cosmetics. Asia-Pacific leads the market, while North America remains a major demand center for dietary supplements and generic drugs.

Why it matters: - Microcrystalline cellulose is moving beyond a basic excipient and into a higher-value input for drugs, food and cosmetics. - The market’s projected rise to about $2.72 billion by 2035 signals steady demand across regulated and consumer-facing industries. - The shift toward cleaner labels and plant-derived ingredients is expanding use cases and reshaping supply chains.

What happened: - The global microcrystalline cellulose market was valued at an estimated $1.46 billion in 2025. - The market is projected to grow from $1.54 billion in 2026 to about $2.72 billion by 2035. - That implies a 6.85% compound annual growth rate through 2035. - North America held about $0.40 billion in market value in 2025. - Asia-Pacific held the largest regional share at about 40.12% in 2025.

The details: - Steam-explosion processing is the fastest-growing production method, projected to grow at a 7.32% CAGR through 2035. - A single steam-explosion line can deliver 30% higher throughput than an equivalent acid-hydrolysis system while using 25% less electricity. - Capex for a 10,000-metric-ton-per-year steam-explosion plant is about $18 million to $22 million. - Acid hydrolysis remains the largest process segment, generating about $580 million in 2025. - Wood-based sources held about 61.34% of revenue in 2025. - Non-wood sources such as cotton linters, bamboo residue and sugarcane bagasse are the fastest-growing source segment, projected at a 7.58% CAGR. - Pharmaceuticals accounted for about 46.10% of revenue in 2025. - More than 65% of immediate-release tablet formulations list microcrystalline cellulose as a primary excipient component. - The food sector generated about $280 million in 2025. - Cosmetics is the fastest-growing end-user segment, advancing at a 7.52% CAGR. - Other end uses, including agricultural feed additives and industrial filtration, are growing at a 5.45% CAGR. - Dietary supplement ingredient makers are using cellulose powder as a capsule filler and flow aid.

Between the lines: - The market is being pulled by regulation as much as by product demand. - European clean-label rules, FDA excipient qualification guidance and pharma localization policies are all favoring validated cellulose supply chains. - Producers with strong regulatory files, local feedstock access and lower-emission processing methods appear best positioned. - North America’s $0.40 billion market value reflects the region’s dependence on generic drug manufacturing and supplement ingredients. - India and China are central to future supply growth because of pharma output, capacity expansion and feedstock development.

What's next: - Steam-explosion and enzyme-mediated production are likely to keep taking share from older batch acid-hydrolysis systems. - EU food reformulation requirements should continue increasing demand for cellulose-based excipients through 2027 and beyond. - Cosmetics formulators are expected to keep qualifying cosmetics-grade purified cellulose as brands target bio-based ingredient goals. - Non-wood sourcing in India and Brazil may expand as producers seek lower raw-material costs and regional supply security. - Competition will likely stay centered on process efficiency, regulatory coverage and proximity to major tablet, food and cosmetics manufacturers.

The bottom line: - Microcrystalline cellulose is becoming a strategic material, not just a commodity excipient.